Spectrum Pharmaceuticals
SPPI
$1.03
Share price
0.00%
Change (1 day)
17.05%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $80.87 M
According to Spectrum Pharmaceuticals 's latest financial reports the company's total liabilities are $80.87 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Spectrum Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $75.45 M | 17.9% |
| 2021-12-31 | $63.99 M | 2.3% |
| 2020-12-31 | $62.55 M | -14.36% |
| 2019-12-31 | $73.04 M | -32.13% |
| 2018-12-31 | $0.10 B | -20.92% |
| 2017-12-31 | $0.13 B | -29.39% |
| 2016-12-31 | $0.19 B | -7.5% |
| 2015-12-31 | $0.20 B | -11.52% |
| 2014-12-31 | $0.23 B | 8.24% |
| 2013-12-31 | $0.21 B | -1.75% |
| 2012-12-31 | $0.22 B | 138.42% |
| 2011-12-31 | $92.87 M | 4.17% |
| 2010-12-31 | $89.15 M | 37.57% |
| 2009-12-31 | $64.8 M | -8.53% |
| 2008-12-31 | $70.85 M | 705.98% |
| 2007-12-31 | $8.79 M | 20.95% |
| 2006-12-31 | $7.26 M | 78.62% |
| 2005-12-31 | $4.06 M | 43.07% |
| 2004-12-31 | $2.84 M | -8.49% |
| 2003-12-31 | $3.1 M | 11.77% |
| 2002-12-31 | $2.78 M | -53.94% |
| 2001-12-31 | $6.03 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 122,051.60% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | 65,678.41% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 169,571.08% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 42,421.33% | 🇺🇸 USA |
 Biogen BIIB | $12.04 B | 14,794.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 81,109.35% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 72,640.57% | 🇬🇧 UK |
 Seagen
SGEN | $1.08 B | 1,240.23% | 🇺🇸 USA |
 Curis CRIS | $57.61 M | -28.76% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 43,615.84% | 🇮🇱 Israel |